Cytopath Biopsy Lab Inc - NY Westchester, Mamaroneck 10543

Cytopath Biopsy Lab Inc entered the industry of Doctors in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $10.000.000 to $19.9999.999. The NAICS classifies this business under the code 6211110, which describes it as a Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Doctors. The business provides service to the B2C market.

To acquire more information, please contact Zuber Nakadar, Office Manager by calling (914) 698-5706 during business hours. You can also write to the business’ Single Location at 715 Mamaroneck Avenue, Mamaroneck, New York NY 10543. You can also visit the company’s website at cblpath.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Cytopath Biopsy Lab Inc
Representative: Zuber Nakadar, Office Manager
Place of Business: 715 Mamaroneck Avenue, Mamaroneck, NY 10543
Contact Number: (914) 698-5706
Website: cblpath.com
Type of Service: Doctors
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Income/Year: $10.000.000 to $19.9999.999
Laborers: 1 to 4
Share This Company:

Cytopath Biopsy Lab Inc is a company operating from Westchester, New York providing professional Doctors and relevant B2C variables. It was founded in 0 and registered with the SIC code 8011 as Doctors, and with the NAICS code 6211110 as Doctors.

With a current employee count of 1 to 4, Cytopath Biopsy Lab Inc has gone to report making $10.000.000 to $19.9999.999 per annum on its journey towards growth. This company invites you to contact its representative Zuber Nakadar, Office Manager at (914) 698-5706 for related queries, or to locate its Single Location using the coordinates 40.95595,-73.73845.

The Single Location can also be found at the street address 715 Mamaroneck Avenue in Mamaroneck, New York 10543 and can be engaged online through the company website at cblpath.com, the company Twitter , and Facebook page .